Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an ...

Moderna, searching for a rebound, to seek approval of mRNA flu shot

The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.
TipRanks on MSN

Moderna highlights 2025 progress and strengthened vaccine portfolio

An update from Moderna ( ($MRNA) ) is now available. In a January 5, 2026 letter to shareholders, Moderna reviewed a challenging 2025 operating ...

Moderna secures up to $54.3 million funding for bird flu vaccine from global coalition

Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental bird flu vaccine, the U.S. drugmaker said on Thursday.
CNA

Novavax COVID-19 vaccine available at some GP clinics until May 31

The JN.1 Novavax vaccine is an alternative to the LP.8.1 Pfizer-BioNTech and Moderna vaccines that were rolled out in October ...
Seeking Alpha

Moderna's Vaccine Progress Undermined By RSV Market Contraction (Rating Downgrade)

Moderna, Inc.'s combination flu and COVID-19 vaccine, mRNA-1083, showed strong Phase 3 results in adults over 50. Pfizer/BioNTech's combination vaccine faced setbacks, giving Moderna a potential ...
Acsh.org

Moderna's mRNA Norovirus Vaccine Trials: To Hurl or Not to Hurl. That's the Endpoint.

Norovirus vaccines face significant hurdles, with virtually no success from past efforts from HilleVax and Vaxxart. But Moderna's mRNA-1403, now in Phase 3 trials, is based on the company's mRNA ...
Yahoo

FDA clears Moderna’s new COVID vaccine, but with limits

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. CHICAGO — The Food and Drug Administration has granted ...
CBS News

Moderna says its combination COVID and flu vaccine tested better than separate shots

CAMBRIDGE - Moderna announced Monday that its combination COVID and flu vaccine showed positive results in a late-stage trial. The Cambridge, Massachusetts-based biotech company said the mRNA-1083 ...

Moderna (MRNA): Reassessing Valuation After a Modest Share Price Rebound

Moderna (MRNA) has been quietly grinding higher, with the stock up roughly 11% over the past month and 12% in the past 3 ...
TipRanks on MSN

Moderna announces global regulatory submissions for seasonal influenza vaccine

Moderna (MRNA) provided an update on regulatory submissions for its investigational seasonal influenza vaccine, mRNA-1010, for adults aged 50 ...

Moderna, Inc.: Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine

Moderna has filed for marketing authorization in the U.S., EU, Canada and Australia for mRNA-1010 CAMBRIDGE, MA / ACCESS Newswire / January 5, 2026 / Moderna, Inc. (NASDAQ:MRNA) today provided an upda ...